STrategies to incRease confidence InDependence and Energy (STRIDE)

Conditions

Age and ageing Mental and Behavioural Disorders

Parry SW, Bamford C, Deary V, Finch TL, Gray J, MacDonald C, McMeekin P, Sabin NJ, Steen IN, Whitney SL, McColl EM.

2016-07-0163 citations

10.3310/hta20560

The STRIDE (Strategies to Increase confidence, InDependence and Energy) study: cognitive behavioural therapy-based intervention to reduce fear of falling in older fallers living in the community - study protocol for a randomised controlled trial

Steve W. Parry, Vincent Deary, Tracy Finch, Claire Bamford, Neil Sabin et al. (12 authors)

Trials2014-06-0629 citations

10.1186/1745-6215-15-210

Interventions

Cognitive behavioural therapy delivered by trained healthcare assistants. Followed up after 12 month(s)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patient has provided written informed consent for participation in the study 2. Age 60 years and over 3. Clinically significant fear of falling as defined by a Falls Efficacy ScaleInternational Version score of greater than 23 4. Male and female participants

Exclusion criteria

Exclusion criteria: 1.Patients with cognitive impairment (mini-mental state examination MMSE less than 24) 2. Life expectancy less than 1 year or unlikely for any other reason to be unable to complete one year follow-up duration 3. Patients requiring psychosocial interventions unrelated to fear of falling 4. Current involvement in other investigational studies or trials, or involvement within 30 days prior to study entry 5. Patients who have taken part in part 1 of the study

Design outcomes

Primary

Measure	Time frame
Change in fear of falling as measured by the Falls Efficacy Scale International (FES-I) measured at 12 months.	—

Secondary

Measure	Time frame
1. Cost Effectiveness measured at 6 months and 12 months post randomisation 2. EUROHIS-QOL-8 and WHO QOL OLD measured at 8 weeks, 6 months and 12 months post randomisation 3. EuroQoL-5 Dimensions Scale measured at 8 weeks, 6 months and 12 months post randomisation 4. Falls measured throughout follow-up 5. Functional Reach measured at 8 weeks, 6 months and 12 months post randomisation 6. Hospital Anxiety & Depression Score (HADS) measured at 8 weeks, 6 months and 12 months post randomisation 7. Isometric Hand Grip Strength measured at 8 weeks, 6 months and 12 months post randomisation; Lubben Social Network Scale 6; Timepoint(s): 8 weeks, 6 months and 12 months post randomisation 8. Numeric rating scale for fear of falling when walking measured at 8 weeks, 6 months and 12 months post randomisation 9. Patient Generated Index (PGI) measured at 8 weeks, 6 months and 12 months post randomisation 10. Short Form 36 (SF-36) measured at 8 weeks, 6 months and 12 months post randomisation 11. Short Physical Performance Battery measured at 8 weeks, 6 months and 12 months post randomisation 12. Social Participation Questionnaire measured at 8 weeks, 6 months and 12 months post randomisation 13. The De Jong-Gierveld Loneliness Scale measured at 8 weeks, 6 months and 12 months post randomisation	—

Measure

Time frame

1. Cost Effectiveness measured at 6 months and 12 months post randomisation 2. EUROHIS-QOL-8 and WHO QOL OLD measured at 8 weeks, 6 months and 12 months post randomisation 3. EuroQoL-5 Dimensions Scale measured at 8 weeks, 6 months and 12 months post randomisation 4. Falls measured throughout follow-up 5. Functional Reach measured at 8 weeks, 6 months and 12 months post randomisation 6. Hospital Anxiety & Depression Score (HADS) measured at 8 weeks, 6 months and 12 months post randomisation 7. Isometric Hand Grip Strength measured at 8 weeks, 6 months and 12 months post randomisation; Lubben Social Network Scale 6; Timepoint(s): 8 weeks, 6 months and 12 months post randomisation 8. Numeric rating scale for fear of falling when walking measured at 8 weeks, 6 months and 12 months post randomisation 9. Patient Generated Index (PGI) measured at 8 weeks, 6 months and 12 months post randomisation 10. Short Form 36 (SF-36) measured at 8 weeks, 6 months and 12 months post randomisation 11. Short Physical Performance Battery measured at 8 weeks, 6 months and 12 months post randomisation 12. Social Participation Questionnaire measured at 8 weeks, 6 months and 12 months post randomisation 13. The De Jong-Gierveld Loneliness Scale measured at 8 weeks, 6 months and 12 months post randomisation

—

Countries

United Kingdom

Outcome results

None listed